ArticleRSC advances2025
Design and computational screening of high-energy, low-sensitivity bistetrazole-based energetic molecules.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bistetrazole-based compounds are novel high-nitrogen energetic molecules that have garnered attention in recent years. They possess a higher energy density and lower sensitivity, and are less challenging to synthesize than complex cage-like molecules. This study employed a molecular auto-generation mechanism to generate 35 322 bistetrazole-based molecules with 20 bridgeheads and 29 side substituents. A combination of quantum chemical calculations and machine learning models was used to sequentially screen the molecules based on their oxygen balance index, synthesis difficulty, density, and detonation pressure, thus rapidly narrowing the search scope. Three bistetrazole-based energetic molecules with high potential were identified. The theoretical enthalpy of the formation of the designed molecules was as high as 854.76 kJ mol
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.